Global Neurogenetic Testing Competitive Landscape Professional Research Report 2024
Description
Global Neurogenetic Testing Competitive Landscape Professional Research Report 2024
Research Summary
Neurogenetic testing refers to a specialized type of genetic testing that focuses on evaluating an individual’s genetic makeup specifically related to neurological conditions and diseases. It involves analyzing genetic variations, mutations, or abnormalities that may be associated with neurological disorders, such as Alzheimer’s disease, Parkinson’s disease, epilepsy, or hereditary neuropathies. Neurogenetic testing typically involves extracting DNA from a patient’s blood or saliva sample, followed by sequencing and analyzing specific genes or regions of the genome relevant to neurological conditions. The results of neurogenetic testing can provide valuable insights into the underlying genetic factors contributing to a person’s neurological symptoms or predisposition to certain disorders, helping with diagnosis, treatment decisions, and the assessment of disease risk for individuals and their families. Additionally, neurogenetic testing plays a significant role in advancing our understanding of the genetic basis of neurological diseases and in the development of personalized therapies in the field of neurology.
According to DIResearch's in-depth investigation and research, the global Neurogenetic Testing market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.
The major global manufacturers of Neurogenetic Testing include Quest Diagnostics, Mayo Clinic, GeneDx, Illumina, Labcorp, Invitae, Connecticut Children’s, MedGenome Labs, CENTOGENE, Victorian Clinical Genetics Services, PacBio etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Neurogenetic Testing. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Neurogenetic Testing market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Neurogenetic Testing market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Neurogenetic Testing industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Neurogenetic Testing Include:
Quest Diagnostics
Mayo Clinic
GeneDx
Illumina
Labcorp
Invitae
Connecticut Children’s
MedGenome Labs
CENTOGENE
Victorian Clinical Genetics Services
PacBio
Neurogenetic Testing Product Segment Include:
Exome Sequencing
Whole Genome Sequencing
RNA Sequencing
General DNA Testing
Neurogenetic Testing Product Application Include:
Hospitals
Specialty Clinics
Research Institutes
Diagnostics Laboratories
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Neurogenetic Testing Industry PESTEL Analysis
Chapter 3: Global Neurogenetic Testing Industry Porter’s Five Forces Analysis
Chapter 4: Global Neurogenetic Testing Major Regional Market Size and Forecast Analysis
Chapter 5: Global Neurogenetic Testing Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Neurogenetic Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Neurogenetic Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Neurogenetic Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Neurogenetic Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Neurogenetic Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Neurogenetic Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Neurogenetic Testing Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Neurogenetic Testing Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Neurogenetic Testing Product by Type
- 1.2.1 Global Neurogenetic Testing Market Size by Type, 2023 VS 2024 VS 2030
- 1.2.2 Exome Sequencing
- 1.2.3 Whole Genome Sequencing
- 1.2.4 RNA Sequencing
- 1.2.5 General DNA Testing
- 1.3 Neurogenetic Testing Product by Application
- 1.3.1 Global Neurogenetic Testing Market Size by Application, 2023 VS 2024 VS 2030
- 1.3.2 Hospitals
- 1.3.3 Specialty Clinics
- 1.3.4 Research Institutes
- 1.3.5 Diagnostics Laboratories
- 1.4 Global Neurogenetic Testing Market Revenue Analysis (2019-2030)
- 1.5 Neurogenetic Testing Market Development Status and Trends
- 1.5.1 Neurogenetic Testing Industry Development Status Analysis
- 1.5.2 Neurogenetic Testing Industry Development Trends Analysis
- 2 Neurogenetic Testing Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Neurogenetic Testing Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Neurogenetic Testing Market Analysis by Regions
- 4.1 Neurogenetic Testing Overall Market: 2023 VS 2024 VS 2030
- 4.2 Global Neurogenetic Testing Revenue and Forecast Analysis (2019-2030)
- 4.2.1 Global Neurogenetic Testing Revenue and Market Share by Region (2019-2024)
- 4.2.2 Global Neurogenetic Testing Revenue Forecast by Region (2025-2030)
- 5 Global Neurogenetic Testing Market Size by Type and Application
- 5.1 Global Neurogenetic Testing Market Size by Type
- 5.2 Global Neurogenetic Testing Market Size by Application
- 6 North America
- 6.1 North America Neurogenetic Testing Market Size and Growth Rate Analysis (2019-2030)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Neurogenetic Testing Market Size by Type
- 6.4 North America Neurogenetic Testing Market Size by Application
- 6.5 North America Neurogenetic Testing Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Neurogenetic Testing Market Size and Growth Rate Analysis (2019-2030)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Neurogenetic Testing Market Size by Type
- 7.4 Europe Neurogenetic Testing Market Size by Application
- 7.5 Europe Neurogenetic Testing Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Neurogenetic Testing Market Size and Growth Rate Analysis (2019-2030)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Neurogenetic Testing Market Size by Type
- 8.4 China Neurogenetic Testing Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Neurogenetic Testing Market Size and Growth Rate Analysis (2019-2030)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Neurogenetic Testing Market Size by Type
- 9.4 APAC (excl. China) Neurogenetic Testing Market Size by Application
- 9.5 APAC (excl. China) Neurogenetic Testing Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Indonesia
- 9.5.6 Vietnam
- 9.5.7 Malaysia
- 9.5.8 Thailand
- 10 Latin America
- 10.1 Latin America Neurogenetic Testing Market Size and Growth Rate Analysis (2019-2030)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Neurogenetic Testing Market Size by Type
- 10.4 Latin America Neurogenetic Testing Market Size by Application
- 10.5 Latin America Neurogenetic Testing Market Size by Country
- 10.5.1 Mecixo
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Neurogenetic Testing Market Size and Growth Rate Analysis (2019-2030)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Neurogenetic Testing Market Size by Type
- 11.4 Middle East & Africa Neurogenetic Testing Market Size by Application
- 11.5 Middle East & Africa Neurogenetic Testing Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Market Competition by Manufacturers
- 12.1 Global Neurogenetic Testing Market Revenue by Key Manufacturers (2020-2024)
- 12.2 Neurogenetic Testing Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Neurogenetic Testing Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Quest Diagnostics
- 13.1.1 Quest Diagnostics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Quest Diagnostics Neurogenetic Testing Product Portfolio
- 13.1.3 Quest Diagnostics Neurogenetic Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.2 Mayo Clinic
- 13.2.1 Mayo Clinic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Mayo Clinic Neurogenetic Testing Product Portfolio
- 13.2.3 Mayo Clinic Neurogenetic Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.3 GeneDx
- 13.3.1 GeneDx Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 GeneDx Neurogenetic Testing Product Portfolio
- 13.3.3 GeneDx Neurogenetic Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.4 Illumina
- 13.4.1 Illumina Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Illumina Neurogenetic Testing Product Portfolio
- 13.4.3 Illumina Neurogenetic Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.5 Labcorp
- 13.5.1 Labcorp Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Labcorp Neurogenetic Testing Product Portfolio
- 13.5.3 Labcorp Neurogenetic Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.6 Invitae
- 13.6.1 Invitae Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Invitae Neurogenetic Testing Product Portfolio
- 13.6.3 Invitae Neurogenetic Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.7 Connecticut Children’s
- 13.7.1 Connecticut Children’s Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Connecticut Children’s Neurogenetic Testing Product Portfolio
- 13.7.3 Connecticut Children’s Neurogenetic Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.8 MedGenome Labs
- 13.8.1 MedGenome Labs Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 MedGenome Labs Neurogenetic Testing Product Portfolio
- 13.8.3 MedGenome Labs Neurogenetic Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.9 CENTOGENE
- 13.9.1 CENTOGENE Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 CENTOGENE Neurogenetic Testing Product Portfolio
- 13.9.3 CENTOGENE Neurogenetic Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.10 Victorian Clinical Genetics Services
- 13.10.1 Victorian Clinical Genetics Services Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Victorian Clinical Genetics Services Neurogenetic Testing Product Portfolio
- 13.10.3 Victorian Clinical Genetics Services Neurogenetic Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.11 PacBio
- 13.11.1 PacBio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 PacBio Neurogenetic Testing Product Portfolio
- 13.11.3 PacBio Neurogenetic Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 14 Industry Chain Analysis
- 14.1 Neurogenetic Testing Industry Chain Analysis
- 14.2 Neurogenetic Testing Industry Raw Material and Suppliers Analysis
- 14.2.1 Upstream Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Neurogenetic Testing Typical Downstream Customers
- 14.4 Neurogenetic Testing Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
